BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 29377611)

  • 21. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder.
    Richards C; Powis L; Moss J; Stinton C; Nelson L; Oliver C
    J Neurodev Disord; 2017 Nov; 9(1):37. PubMed ID: 29126394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc deficiency and supplementation in autism spectrum disorder and Phelan-McDermid syndrome.
    Alsufiani HM; Alkhanbashi AS; Laswad NAB; Bakhadher KK; Alghamdi SA; Tayeb HO; Tarazi FI
    J Neurosci Res; 2022 Apr; 100(4):970-978. PubMed ID: 35114017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders.
    Grabrucker S; Jannetti L; Eckert M; Gaub S; Chhabra R; Pfaender S; Mangus K; Reddy PP; Rankovic V; Schmeisser MJ; Kreutz MR; Ehret G; Boeckers TM; Grabrucker AM
    Brain; 2014 Jan; 137(Pt 1):137-52. PubMed ID: 24277719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe white matter damage in SHANK3 deficiency: a human and translational study.
    Jesse S; Müller HP; Schoen M; Asoglu H; Bockmann J; Huppertz HJ; Rasche V; Ludolph AC; Boeckers TM; Kassubek J
    Ann Clin Transl Neurol; 2020 Jan; 7(1):46-58. PubMed ID: 31788990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.
    Vicidomini C; Ponzoni L; Lim D; Schmeisser MJ; Reim D; Morello N; Orellana D; Tozzi A; Durante V; Scalmani P; Mantegazza M; Genazzani AA; Giustetto M; Sala M; Calabresi P; Boeckers TM; Sala C; Verpelli C
    Mol Psychiatry; 2017 May; 22(5):689-702. PubMed ID: 27021819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency.
    Bidinosti M; Botta P; Krüttner S; Proenca CC; Stoehr N; Bernhard M; Fruh I; Mueller M; Bonenfant D; Voshol H; Carbone W; Neal SJ; McTighe SM; Roma G; Dolmetsch RE; Porter JA; Caroni P; Bouwmeester T; Lüthi A; Galimberti I
    Science; 2016 Mar; 351(6278):1199-203. PubMed ID: 26847545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shank3-deficient rats exhibit degraded cortical responses to sound.
    Engineer CT; Rahebi KC; Borland MS; Buell EP; Im KW; Wilson LG; Sharma P; Vanneste S; Harony-Nicolas H; Buxbaum JD; Kilgard MP
    Autism Res; 2018 Jan; 11(1):59-68. PubMed ID: 29052348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Restoration of
    Jaramillo TC; Xuan Z; Reimers JM; Escamilla CO; Liu S; Powell CM
    eNeuro; 2020; 7(3):. PubMed ID: 32327468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons.
    Yi F; Danko T; Botelho SC; Patzke C; Pak C; Wernig M; Südhof TC
    Science; 2016 May; 352(6286):aaf2669. PubMed ID: 26966193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Intestinal Morphology and Microbiota Composition in the Autism Spectrum Disorders Associated SHANK3 Mouse Model.
    Sauer AK; Bockmann J; Steinestel K; Boeckers TM; Grabrucker AM
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An IGFBP2-derived peptide promotes neuroplasticity and rescues deficits in a mouse model of Phelan-McDermid syndrome.
    Burgdorf JS; Yoon S; Dos Santos M; Lammert CR; Moskal JR; Penzes P
    Mol Psychiatry; 2023 Mar; 28(3):1101-1111. PubMed ID: 36481930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disrupted extracellular matrix and cell cycle genes in autism-associated Shank3 deficiency are targeted by lithium.
    Ioannidis V; Pandey R; Bauer HF; Schön M; Bockmann J; Boeckers TM; Lutz AK
    Mol Psychiatry; 2024 Mar; 29(3):704-717. PubMed ID: 38123724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Genetic Aspects of Phelan-McDermid Syndrome: An Interdisciplinary Approach to Management.
    Cammarata-Scalisi F; Callea M; Martinelli D; Willoughby CE; Tadich AC; Araya Castillo M; Lacruz-Rengel MA; Medina M; Grimaldi P; Bertini E; Nevado J
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models.
    Thibaudeau A; Schmitt K; François L; Chatrousse L; Hoffmann D; Cousin L; Weiss A; Vuidel A; Jacob CB; Sommer P; Benchoua A; Wilbertz JH
    Transl Psychiatry; 2024 Jun; 14(1):249. PubMed ID: 38858349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homer1a regulates Shank3 expression and underlies behavioral vulnerability to stress in a model of Phelan-McDermid syndrome.
    Lin R; Learman LN; Bangash MA; Melnikova T; Leyder E; Reddy SC; Naidoo N; Park JM; Savonenko A; Worley PF
    Cell Rep; 2021 Nov; 37(7):110014. PubMed ID: 34788607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational pediatrics: clinical perspective for Phelan-McDermid syndrome and autism research.
    Sakai Y; Okuzono S; Schaaf CP; Ohga S
    Pediatr Res; 2022 Aug; 92(2):373-377. PubMed ID: 34702975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function.
    Jaramillo TC; Speed HE; Xuan Z; Reimers JM; Escamilla CO; Weaver TP; Liu S; Filonova I; Powell CM
    Autism Res; 2017 Jan; 10(1):42-65. PubMed ID: 27492494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive follow-up in adult siblings with Phelan-McDermid syndrome due to a novel SHANK3 splicing site mutation.
    Kankuri-Tammilehto M; Sauna-Aho O; Arvio M
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1780. PubMed ID: 34369668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports.
    Serret S; Thümmler S; Dor E; Vesperini S; Santos A; Askenazy F
    BMC Psychiatry; 2015 May; 15():107. PubMed ID: 25947967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 16p11.2 Deletion Syndrome Mice Display Sensory and Ultrasonic Vocalization Deficits During Social Interactions.
    Yang M; Mahrt EJ; Lewis F; Foley G; Portmann T; Dolmetsch RE; Portfors CV; Crawley JN
    Autism Res; 2015 Oct; 8(5):507-21. PubMed ID: 25663600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.